Companies / IASO Bio
IASO Bio
Nanjing, China
IASO Bio develops and manufactures biotherapies, including cell therapies and CAR-T treatments, for hematologic malignancies and autoimmune diseases.
IASO Bio, based in Nanjing, China, has 2 investors on file, among them ClavystBio and Plaisance Capital Management. Its site was last checked 20 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from ClavystBio
16 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%), Robotics & Hardware (7%), AI & Machine Learning (7%).
More from Plaisance Capital Management
10 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Plaisance Capital Management's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get IASO Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when ClavystBio adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/iasobio.com/investors
# also
GET /v1/companies/iasobio.com
GET /v1/companies/iasobio.com/news